New corona vaccine developed by Russian research group Published in British medical magazine September 5, 7:31
A research group developing a new coronavirus vaccine in Russia confirmed an increase in the level of “antibody”, which plays an immunological role, with the officially approved vaccine “Sputnik V”, as well as serious health problems. A report was published in a British medical journal stating that no effects were seen.
A research group developing a new coronavirus vaccine "Sputnik V" in Russia reported the results of early-stage clinical trials in the British medical journal "Lancet".
According to it, the study was conducted in 76 people aged 18 to 60 years, and examined the safety and the change of the antibody level after receiving the vaccination.
As a result, about half of them had headache and fever symptoms within 42 days after the vaccination, but no serious health effects were reported.
We also confirmed that all 40 people who were vaccinated twice had "neutralizing antibodies" that weaken the function of the new coronavirus, and reported that the antibody levels were higher than those naturally infected.
The Russian government has officially approved the use of "Sputnik V" without waiting for the third stage clinical trial, which is the final stage of development, and announced plans to start large-scale vaccination in November.
Regarding the new coronavirus vaccine, an exceptional vaccination of the vaccine under development in China has begun, and the United States is preparing for the start of supply in November.